Role of EZH2 histone methyltrasferase in melanoma progression and metastasis
- PMID: 27105109
- PMCID: PMC4990393
- DOI: 10.1080/15384047.2016.1167291
Role of EZH2 histone methyltrasferase in melanoma progression and metastasis
Abstract
There is accumulating evidence that the histone methyltransferase enhancer of zeste homolog 2 (EZH2), the main component of the polycomb-repressive complex 2 (PRC2), is involved in melanoma progression and metastasis. Novel drugs that target and reverse such epigenetic changes may find a way into the management of patients with advanced melanoma. We provide a comprehensive up-to-date review of the role and biology of EZH2 on gene transcription, senescence/apoptosis, melanoma microenvironment, melanocyte stem cells, the immune system, and micro RNA. Furthermore, we discuss EZH2 inhibitors as potential anti-cancer therapy.
Keywords: Chromatin; EZH2; H3K27 trimethylation; epigenetic changes; histone; melanoma; polycomb-repressive complex.
Figures
Similar articles
-
Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy.Cell Rep. 2021 Jul 20;36(3):109410. doi: 10.1016/j.celrep.2021.109410. Cell Rep. 2021. PMID: 34289358 Free PMC article.
-
Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells.Hypertension. 2012 Nov;60(5):1176-83. doi: 10.1161/HYPERTENSIONAHA.112.191098. Epub 2012 Sep 10. Hypertension. 2012. PMID: 22966008
-
Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.Mol Cancer Ther. 2006 Dec;5(12):3096-104. doi: 10.1158/1535-7163.MCT-06-0418. Mol Cancer Ther. 2006. PMID: 17172412
-
Noncanonical Functions of the Polycomb Group Protein EZH2 in Breast Cancer.Am J Pathol. 2021 May;191(5):774-783. doi: 10.1016/j.ajpath.2021.01.013. Epub 2021 Feb 6. Am J Pathol. 2021. PMID: 33556366 Free PMC article. Review.
-
The roles of EZH2 in cancer and its inhibitors.Med Oncol. 2023 May 6;40(6):167. doi: 10.1007/s12032-023-02025-6. Med Oncol. 2023. PMID: 37148376 Free PMC article. Review.
Cited by
-
Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack.Cancer Biol Ther. 2017 Jul 3;18(7):451-469. doi: 10.1080/15384047.2017.1323596. Epub 2017 May 17. Cancer Biol Ther. 2017. PMID: 28513269 Free PMC article. Review.
-
Isothiocyanates Potentiate Tazemetostat-Induced Apoptosis by Modulating the Expression of Apoptotic Genes, Members of Polycomb Repressive Complex 2, and Levels of Tri-Methylating Lysine 27 at Histone 3 in Human Malignant Melanoma Cells.Int J Mol Sci. 2024 Feb 27;25(5):2745. doi: 10.3390/ijms25052745. Int J Mol Sci. 2024. PMID: 38473991 Free PMC article.
-
Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combination therapy.J Transl Med. 2017 Dec 4;15(1):243. doi: 10.1186/s12967-017-1344-z. J Transl Med. 2017. PMID: 29202777 Free PMC article.
-
The interplay of CDK4 and CDK6 in melanoma.Oncotarget. 2019 Feb 15;10(14):1346-1359. doi: 10.18632/oncotarget.26515. eCollection 2019 Feb 15. Oncotarget. 2019. PMID: 30858922 Free PMC article.
-
EZH2 inhibition induces senescence via ERK1/2 signaling pathway in multiple myeloma.Acta Biochim Biophys Sin (Shanghai). 2024 May 27;56(7):1055-1064. doi: 10.3724/abbs.2024077. Acta Biochim Biophys Sin (Shanghai). 2024. PMID: 38804044 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016. January; 66(1):7-30; PMID:26742998; http://dx.doi.org/10.3322/caac.21332 - DOI - PubMed
-
- Atrash S, Makhoul I, Mizell JS, Hutchins L, Mahmoud F. Response of metastatic mucosal melanoma to immunotherapy: It can get worse before it gets better. J Oncol Pharm Pract 2016. January 24; PMID:26811403 - PubMed
-
- Larkin J, Hodi FS, Wolchok JD. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N Engl J Med. 2015. September 24; 373(13):1270-1; PMID:26398076; http://dx.doi.org/10.1056/NEJMc1509660 - DOI - PubMed
-
- Buchbinder EI, Hodi FS. Melanoma in 2015: Immune-checkpoint blockade - durable cancer control. Nat Rev Clin Oncol 2016. February; 13(2):77-8; PMID:26787285; http://dx.doi.org/10.1038/nrclinonc.2015.237 - DOI - PubMed
-
- Berger SL. The complex language of chromatin regulation during transcription. Nature 2007. May 24; 447(7143):407-12; PMID:17522673; http://dx.doi.org/10.1038/nature05915 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical